Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
7.45M
-
Shares change
-
+7.45M
-
Total reported value, excl. options
-
$128M
-
Value change
-
+$128M
-
Number of buys
-
34
-
Price
-
$17.35
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2015
34 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q1 2015.
Ascendis Pharma A/S - ADR (ASND) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.45M shares
of 55.6M outstanding shares and own 13.41% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (1.45M shares), FMR LLC (981K shares), VHCP Management, LLC (811K shares), Sectoral Asset Management Inc (732K shares), RS INVESTMENT MANAGEMENT CO LLC (656K shares), Pictet Asset Management Ltd (349K shares), GREAT POINT PARTNERS LLC (340K shares), Visium Asset Management, LP (275K shares), Longwood Capital Partners LLC (229K shares), and LAZARD ASSET MANAGEMENT LLC (205K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.